Substance Use and Psychotic Disorders: From identifying global challenges to addressing gaps
Christian G. Schütz, Katleen T. Brady, Ahmadi Pooria, Khojasteh ArashLecture Hall 221 (ESA West)
Concurrent substance use and psychotic disorders pose significant challenges for healthcare systems worldwide, demanding integrative and multidimensional approaches to treatment. This workshop will share insights from a recently completed survey on the global landscape of the field. The findings will form the basis for discussions on essential training priorities and recommendations to address foundational infrastructural requirements
Global ISAM Survey: Arash Khojasteh Zonoozi and Pooria Ahamadi will summarize the results from a completed ISAM Global Experts Network (ISAM GEN) based assessment of capacity and needs in the treatment of concurrent Substance Use and Psychotic Disorders. The worldwide assessment is the first step and basis of developing a network to support address the current gaps.
Training Needs for Treatment Providers: Christian G. Schütz will report on an in-depth assessment of the training gaps faced by professionals working with dual-diagnosis patients. Emphasis will be placed on core competencies, interdisciplinary collaboration, and culturally informed care, with recommendations for enhancing workforce readiness to deliver integrated treatment.
Infrastructure Needs for Effective Care Delivery: Kathleen T. Brady will examine systemic barriers and infrastructure needs, focusing on access, resource allocation, and policy support. This session will offer strategic recommendations for building resilient and responsive healthcare systems.
This session is designed for clinicians, policymakers, and researchers committed to advancing care for this vulnerable population. The workshop will combine overview presentations with the possibility to discuss the barriers and options in local context.
This workshop will be complementary to a workshop provided by Solja Niemelä focusing on clinical aspects to treat concurrent substance use and psychosis disorders.